INTO DE WORLD

iNtRON believes that continuous cash-inflow is imperative for a company to maintain its sustainability. Our cash-inflow business model consists of ‘Diagnosis Biz' and ‘Antibiotics Alternative Biz' as a pillars for the company. iNtRON is pursuing the development of diagnostic products that can become a standard for human and animal disease diagnostics including COVID-19, Swine flu, Avian Influenza, VRE superbugs, etc. In our "Antibiotics Alternative Biz" sector, we have been making sales from our antibiotic alternative products for animals in local and overseas markets... Since our foundation, we have made continuous growth in sales of diagnostic products including PCR kits for swine flu, food poisoning, and avian influenza. Since the COVID-19 pandemic, sales and profits in our diagnostic business sector have rapidly increased, and it has grown as the major cash-cow business for iNtRON. We are currently strengthening our overseas network built by COVID-19 diagnostic kit exports to new..

Primary location: Boston United States